Medtronic plc (MDT)
NYSE
Closed
Oct 15, 2026
Day's Range
93.9652 wk Range
73.31Overview - MDT - Medtronic plc
Key Statistics
Valuation
Enterprise Value
129.33B
P/E (Trailing)
‪21.73‬
P/E (Forward)
‪13.79‬
PEG Ratio
‪0.51‬
Price / Sales (TTM)
‪3.01‬
Price / Book
‪2.25‬
EV / EBITDA
‪12.42‬
Profitability
Gross Margin
‪64.98%‬
Profit Margin
‪13.93%‬
Operating Margin
‪19.33%‬
Return on Assets
‪5.11%‬
Return on Equity
‪10.64%‬
Ownership
Shares Outstanding
1.28B
Float
1.27B
Short % of Shares Outstanding
‪1.35%‬
Held by Insiders
‪0.34%‬
Held by Institutions
‪88.66%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪90.11‬
200-Day Avg
‪88.38‬
Dividends
Payout Ratio
‪70.01%‬
Frequency
Quarterly
Analyst Consensus
29 analysts
Average price target
‪$ 97.92‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MDT - Medtronic plc
Peers - MDT - Medtronic plc
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - MDT - Medtronic plc
About
Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and healthcare solutions. Its portfolio spans cardiovascular care, neuroscience, medical surgical products, and diabetes management, supporting the diagnosis, treatment, and monitoring of a wide range of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
